Kumar Neil bought BBIO
March 17, 2026 · Form 4 insider transaction
Kumar Neil bought 104,313 shares of BridgeBio Pharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
104,313
Price
$0.00
Total value
N/A
InsiderKumar Neil
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateMarch 17, 2026
Filing dateMarch 19, 2026
Shares owned after104,313
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.; The RSUs will vest with respect to 1/16th of the underlying shares on May 16, 2026. Thereafter, 1/16th of the underlying shares vest on a quarterly basis, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date. The RSUs have no expiration date.